merkel
cell
carcinoma
mcc
rare
devast
skin
diseas
increas
incid
within
unit
state
poor
prognosi
mcc
patient
limit
understand
mcc
pathogenesi
warrant
innov
treatment
control
mcc
sever
line
evid
point
merkel
cell
polyomaviru
mcpyv
etiolog
agent
mcc
particular
amino
terminu
mcpyv
larg
antigen
lt
express
mcpyvposit
tumor
play
import
role
mcc
oncogenesi
render
ideal
therapeut
target
vaccin
current
studi
develop
dna
vaccin
encod
mcpyv
lt
within
dna
vaccin
identifi
mcpyv
lt
like
contain
ltspecif
helper
epitop
also
creat
ltexpress
tumor
model
use
murin
melanoma
cell
line
character
potenc
dna
vaccin
use
tumorigen
tumor
model
found
dna
vaccin
gener
antitumor
effect
mainli
mediat
cell
tumor
vaccin
mice
thu
immunotherapi
use
dna
vaccin
may
repres
promis
approach
control
mcpyvassoci
lesion
tumor
model
serv
use
model
test
variou
vaccin
strategi
mcc
merkel
cell
carcinoma
mcc
rare
devast
diseas
skin
increas
incid
within
unit
state
current
treatment
option
limit
surgeri
alon
combin
adjuv
radiat
howev
mortal
rate
remain
median
surviv
time
month
limit
understand
pathogenesi
mcc
poor
prognosi
mcc
patient
underscor
need
innov
treatment
control
mcc
recent
new
human
polyomaviru
term
merkel
cell
polyomaviru
mcpyv
discov
associ
mcc
carcinogen
mcpyv
support
sever
line
evid
well
establish
polyomavirus
transform
cell
induc
tumor
experiment
anim
model
mcpyv
detect
mcc
tumor
worldwid
tumor
viru
present
chromosom
integr
copi
characterist
virus
caus
cancer
human
mcpyv
integr
clonal
site
uniqu
patient
indic
viru
present
cell
oncogen
transform
compar
mcpyv
normal
tissu
mcpyv
genom
tumor
tissu
harbor
stop
codon
mutat
larg
antigen
lt
open
read
frame
predict
ablat
viral
replic
capac
specif
truncat
lt
protein
lose
c
termin
helicas
domain
requir
viral
dna
replic
rbinteract
domain
retain
lack
viral
replic
characterist
oncogen
virus
viral
replic
would
caus
death
host
cell
necessari
role
larg
antigen
express
mainten
prolif
capac
surviv
mcpyvposit
mcc
cell
line
harbor
truncat
form
larg
antigen
recent
demonstr
thu
suffici
evid
accumul
provision
consid
mcpyv
etiolog
agent
mcc
explor
therapi
target
viru
import
mcpyv
lt
mcc
oncogenesi
render
potenti
ideal
target
molecular
intervent
uniqu
featur
lt
mcc
protein
alway
truncat
introduct
stop
codon
mutat
describ
stop
codon
predict
truncat
protein
beyond
amino
acid
thu
amino
terminu
mcpyv
lt
repres
ideal
therapeut
target
like
present
express
mcpyvposit
mcc
tumor
play
import
role
mcc
oncogenesi
addit
mcpyv
lt
foreign
antigen
therefor
face
issu
immun
toler
base
potenti
ideal
vaccin
target
sought
develop
vaccin
control
mcc
dna
vaccin
attract
form
vaccin
due
safeti
simplic
stabil
capac
repeat
administr
abil
gener
potent
antigenspecif
cell
immun
review
see
recent
demonstr
cell
infiltr
mcc
tumor
correl
better
prognosi
support
idea
cell
may
play
role
clearanc
mcc
thu
creat
dna
vaccin
gener
potent
antigenspecif
cell
immun
control
mcc
current
studi
gener
dna
vaccin
encod
mcpyv
lt
found
within
dna
vaccin
mcpyv
lt
like
contain
ltspecif
helper
epitop
character
potenc
dna
vaccin
creat
mcc
tumor
model
melanoma
tumor
cell
line
transduc
lentiviru
vector
express
mcc
lt
amino
acid
gener
novel
ltexpress
tumorigen
cell
line
sinc
melanoma
like
merkel
cell
carcinoma
cutan
origin
melanoma
cell
line
suitabl
develop
mcpyv
ltexpress
murin
tumor
model
use
tumorigen
tumor
model
found
dna
vaccin
gener
protect
therapeut
antitumor
effect
mainli
mediat
cell
ltexpress
tumor
mice
studi
show
dna
vaccin
encod
mcpyv
lt
potenti
futur
clinic
applic
control
mcc
mice
week
old
purchas
nation
cancer
institut
frederick
md
anim
maintain
specif
pathogenfre
condit
procedur
perform
accord
approv
protocol
accord
recommend
proper
use
care
experiment
anim
gener
dna
vaccin
encod
truncat
larg
antigen
merkel
cell
polyomaviru
strain
larg
antigen
cdna
nt
codonoptim
synthes
genescript
corpor
piscataway
nj
clone
xbai
noti
site
invitrogen
carlsbad
ca
gener
lentiviru
encod
truncat
larg
antigen
larg
antigen
dna
clone
xbainoti
site
vector
system
bioscienc
mountain
view
ca
gener
vector
contain
two
promot
cmv
promot
larg
antigen
promot
gfp
express
total
overlap
peptid
overlap
amino
acid
span
merkel
cell
polyomaviru
larg
antigen
synthes
genescript
corpor
piscataway
nj
ident
peptid
valid
mass
spectrometr
analysi
puriti
peptid
confirm
highperform
liquid
chromatographi
murin
melanoma
cell
purchas
american
type
cultur
collect
larg
gfpexpress
cell
line
gener
transduct
lentivir
vector
encod
larg
antigen
gfp
lentivir
vector
pcmv
pmdg
transfect
cell
line
use
lipofectamin
invitrogen
carlsbad
ca
usa
virioncontain
supernat
collect
h
transfect
supernat
filter
mm
cellulos
acet
syring
filter
nalgen
rochest
ny
usa
use
infect
cell
presenc
polybren
sigmaaldrich
st
loui
mo
usa
transduc
cell
isol
use
prepar
flow
cytometri
gfp
signal
protein
sort
cell
extract
mper
reagent
equal
amount
protein
g
load
separ
gradient
readi
sdspage
protein
transfer
polyvinyliden
difluorid
membran
biorad
hercul
ca
use
electrophroesi
blot
block
phosphatebuff
salin
pb
tween
pbst
contain
nonfat
milk
h
room
temperatur
membran
probe
antibeta
actin
st
loui
mo
dilut
sera
mice
vaccin
dilut
trisbuff
salin
tween
ttb
h
wash
four
time
ttb
incub
goat
antimous
igg
conjug
alkalin
phosphatas
amersham
piscataway
nj
dilut
ttb
contain
nonfat
milk
membran
wash
four
time
ttb
develop
use
hyperfilmenhanc
chemiluminesc
amersham
piscataway
nj
electroporationmedi
dna
vaccin
perform
method
similar
describ
jacob
et
al
mice
per
group
inject
tibiali
muscl
shave
hind
leg
either
empti
vector
dna
vaccin
dose
l
per
mous
dna
plasmid
dilut
appropri
concentr
total
volum
l
pb
dna
inject
immedi
follow
squar
wave
electropor
inject
site
use
btx
harvard
apparatu
holliston
tweezer
electrod
use
deliv
eight
puls
v
ms
number
dose
deliv
vari
accord
experi
describ
section
mice
per
group
immun
intramuscularli
follow
electropor
either
empti
vector
dna
vaccin
first
day
week
first
day
week
vaccin
mice
challeng
subcutan
right
flank
tumor
cell
per
mous
mice
monitor
evid
tumor
growth
inspect
palpat
mice
per
group
subcutan
inocul
tumor
cell
per
mous
right
flank
day
mice
monitor
evid
tumor
growth
inspect
palpat
tumor
growth
measur
twice
week
start
day
tumor
challeng
bear
mice
treat
empti
vector
dna
vaccin
intramuscularli
follow
electropor
three
time
interv
day
tumor
inocul
mice
per
group
vaccin
dna
empti
vector
dna
vaccin
intramuscularli
follow
electropor
day
vaccin
mice
boost
dose
regimen
day
day
vaccin
mice
intraperiton
inject
monoclon
antibodi
everi
day
day
experi
dose
immun
celldeplet
mice
challeng
tumor
cell
per
mous
subcutan
right
flank
day
mice
monitor
tumor
growth
inspect
palpat
tumor
size
measur
twice
week
tumor
growth
monitor
visual
inspect
palpat
addit
tumor
size
measur
vernier
calip
twice
week
tumor
volum
evalu
use
formula
detect
cell
surfac
intracellular
ifn
perform
use
flow
cytometri
describ
previous
splenocyt
isol
vaccin
mice
incub
overnight
gml
golgiplug
bd
pharmingen
presenc
gml
larg
antigen
overlap
peptid
individu
peptid
supplementari
tabl
wash
twice
facscan
buffer
cell
stain
phycoerythrinconjug
antimous
antibodi
cell
incub
bd
cytofixcytoperm
solut
bd
pharmingen
follow
stain
fitcconjug
antimous
ifn
antibodi
flow
cytometri
analysi
perform
bectondickinson
facscalibur
cellquest
softwar
bd
bioscienc
mountain
view
ca
data
express
mean
sd
repres
least
two
differ
experi
comparison
individu
data
point
made
use
student
ttest
kaplanmei
surviv
curv
analysi
use
evalu
tumor
treatment
experi
p
valu
calcul
use
logrank
test
valu
p
consid
signific
murin
melanoma
cell
transduc
lentivir
vector
contain
mammalian
gene
encod
truncat
form
mcpyv
larg
antigen
control
cytolomegaloviru
cmv
promot
gfp
report
gene
promot
gener
tumorigen
ltexpress
cell
line
success
transduct
lentiviru
would
lead
express
gfp
allow
isol
transduc
tumor
cell
shown
fig
lt
retrovirustransduc
tumor
cell
demonstr
greater
gfp
express
compar
nontransduc
tumor
cell
gfpposit
cell
isol
prepar
flow
cytometri
gfp
signal
character
express
lt
antigen
order
gener
antibodi
lt
antigen
construct
vaccin
encod
mcpyv
lt
mice
vaccin
intramuscularli
follow
electropor
three
time
interv
boost
use
dose
regimen
month
later
outlin
fig
one
week
last
vaccin
sera
vaccin
mice
collect
western
blot
analysi
shown
fig
left
panel
cell
lysat
cell
demonstr
specif
band
consist
size
lt
antigen
comparison
band
absent
cell
lysat
melanoma
cell
confirm
load
cell
lysat
compar
sampl
use
antibodi
specif
beta
actin
load
control
fig
right
panel
thu
data
show
success
creat
murin
ltexpress
tumor
cell
line
immun
mice
vaccin
order
gener
ltspecif
cellmedi
respons
vaccin
mice
empti
vector
use
control
map
ltspecif
andor
cell
epitop
synthes
overlap
peptid
overlap
amino
acid
span
mcpyv
lt
supplementari
tabl
five
pool
contain
individu
peptid
one
pool
contain
peptid
prepar
pool
peptid
incub
splenocyt
mice
vaccin
use
regimen
depict
fig
mice
vaccin
gener
signific
ltspecif
cell
respons
stimul
pool
contain
peptid
fig
comparison
vaccin
mice
gener
number
ltspecif
cell
background
level
stimul
lt
peptid
fig
mice
vaccin
empti
vector
also
fail
gener
signific
ltspecif
cellmedi
respons
supplementari
fig
order
delin
ltspecif
cell
epitop
incub
individu
peptid
pool
contain
peptid
splenocyt
vaccin
mice
shown
fig
splenocyt
vaccin
mice
stimul
peptid
overlap
peptid
demonstr
significantli
greater
ltspecif
cell
immun
respons
compar
splenocyt
stimul
candid
peptid
amino
acid
sequenc
share
peptid
ssssgygsfsasqasd
fig
region
like
contain
core
region
cell
epitop
epitop
map
experi
observ
dna
vaccinegener
ltspecif
cell
immun
respons
potenti
antitumor
effect
howev
shorter
regimen
elicit
level
immun
respons
practic
compar
regimen
use
map
experi
depict
fig
order
determin
whether
abbrevi
regimen
intramuscular
administr
follow
electropor
depict
fig
would
also
gener
robust
lt
peptid
specif
cell
immun
respons
immun
mice
accordingli
perform
intracellular
cytokin
stain
ifnfollow
flow
cytometri
shown
fig
splenocyt
mice
vaccin
stimul
candid
ltspecif
epitop
mcpyv
lt
gener
significantli
greater
number
ifn
secret
ltspecif
cell
compar
splenocyt
mice
vaccin
empti
vector
similarli
stimul
thu
data
indic
vaccin
regimen
use
three
dose
abl
gener
signific
number
ltspecif
cell
use
vaccin
regimen
depict
fig
perform
vivo
tumor
protect
experi
determin
protect
antitumor
effect
dna
vaccin
mice
vaccin
dna
vaccin
control
empti
vector
vaccin
mice
challeng
tumor
cell
subcutan
week
last
vaccin
shown
fig
mice
vaccin
demonstr
significantli
smaller
tumor
volum
mice
vaccin
control
empti
vector
shown
fig
mice
vaccin
significantli
higher
surviv
rate
compar
mice
vaccin
thu
data
show
dna
vaccin
elicit
strong
protect
antitumor
effect
vaccin
mice
determin
whether
dna
vaccin
capabl
gener
therapeut
antitumor
effect
first
inocul
mice
tumor
treat
mice
use
vaccin
regimen
depict
fig
shown
fig
tumorbear
mice
vaccin
significantli
smaller
tumor
volum
mice
vaccin
control
empti
vector
furthermor
tumorbear
mice
vaccin
show
significantli
longer
surviv
compar
mice
vaccin
therefor
data
show
dna
vaccin
capabl
gener
therapeut
antitumor
effect
tumorbear
mice
determin
subset
lymphocyt
import
antitumor
effect
gener
dna
vaccin
perform
vivo
immun
cell
deplet
experi
antiimmun
cell
antibodi
use
regimen
specifi
fig
shown
fig
mice
deplet
cell
grew
tumor
dramat
faster
compar
nondeplet
mice
mice
deplet
cell
nk
cell
deplet
cell
nk
cell
also
led
loss
protect
antitumor
effect
although
loss
signific
deplet
cell
result
indic
subset
lymphocyt
import
antitumor
effect
cell
import
factor
antitumor
immun
gener
dna
vaccin
studi
success
demonstr
dna
vaccin
encod
mcpyv
gener
ltspecif
cell
immun
respons
vaccin
mice
also
identifi
ltspecif
helper
epitop
mcpyv
furthermor
creat
preclin
murin
mcc
tumor
model
suitabl
test
dna
vaccin
character
dna
vaccin
demonstr
vaccin
capabl
gener
potent
protect
therapeut
antitumor
effect
determin
cell
primari
mediat
observ
antitumor
effect
vaccin
mice
tumor
model
repres
innov
avenu
test
vaccin
target
mcpyv
best
knowledg
current
report
preclin
mcc
tumor
model
test
cancer
immunotherapi
present
also
report
vaccin
treat
mcpyvinduc
mcc
tumor
either
preclin
clinic
set
thu
model
serv
potenti
import
tumor
model
test
differ
vaccin
strategi
includ
form
vaccin
peptidebas
proteinbas
dendrit
cellbas
vectorbas
vaccin
target
mcpyv
studi
observ
cell
essenti
observ
antitumor
effect
gener
vaccin
dna
vaccin
shown
cell
immun
respons
gener
antitumor
effect
cutan
tumor
model
furthermor
shown
tumorspecif
cell
differenti
cytotox
cell
lymphopen
mice
mark
express
cytotox
cellassoci
gene
perforin
granzym
b
involv
degranul
cytotox
cell
model
activ
tumorspecif
cell
independ
nk
cell
import
tumor
clearanc
thu
import
explor
role
tumorspecif
cell
mediat
antitumor
immun
direct
cytotox
mechanist
understand
vaccin
work
guid
futur
effort
improv
vaccin
current
studi
show
antitumor
effect
dna
vaccin
primarili
mediat
cell
cell
nk
cell
also
contribut
efficaci
vaccin
tumor
model
fig
although
dna
vaccin
current
studi
gener
appreci
ltspecif
cell
immun
respons
differ
vaccin
strategi
may
potenti
lead
enhanc
ltspecif
cell
exampl
previous
found
dna
vaccin
encod
calreticulin
crt
heat
shock
protein
link
lead
enhanc
cell
immun
respons
import
futur
investig
determin
whether
strategi
induc
ltspecif
cell
immun
respons
futur
clinic
translat
therapeut
mcpyv
vaccin
import
identifi
desir
vaccin
strategi
gener
optim
mcpyv
ltspecif
andor
cell
immun
respons
antitumor
effect
mcpyv
ltexpress
tumor
previous
gener
panel
therapeut
dna
vaccin
employ
variou
intracellular
target
strategi
rout
model
target
antigen
desir
subcellular
compart
order
enhanc
mhc
class
andor
mhc
class
ii
antigen
process
present
pathway
enhanc
antigenspecif
cell
immun
respons
strategi
enhanc
cell
immun
respons
includ
linkag
target
antigen
sort
signal
lysosomeassoci
membran
protein
improv
mhc
class
ii
antigen
present
cell
strategi
enhanc
cell
immun
respons
includ
linkag
target
antigen
mycobacterium
tuberculosi
heatshock
protein
calreticulin
crt
gammatubulin
transloc
domain
dii
pseudomona
aeruginosa
exotoxin
eta
enhanc
mhc
class
antigen
present
cell
dna
vaccin
strategi
proven
effect
antigen
system
review
see
interest
explor
whether
dna
vaccin
strategi
appli
lt
antigen
enhanc
ltspecif
andor
cell
respons
well
therapeut
antitumor
effect
futur
clinic
translat
summari
creat
dna
vaccin
target
mcpyv
lt
also
success
develop
ltexpress
preclin
tumor
model
evalu
ltspecif
dna
vaccin
strategi
studi
serv
import
platform
develop
immunotherapeut
strategi
control
mcpyvassoci
merkel
cell
carcinoma
refer
web
version
pubm
central
supplementari
materi
character
ltspecif
cell
epitop
use
lt
overlap
peptid
splenocyt
mice
vaccin
schemat
diagram
vaccin
regimen
mice
mice
per
group
immun
l
per
mous
intramuscularli
follow
electropor
week
vaccin
mice
boost
dose
regimen
month
later
pool
splenocyt
vaccin
mice
collect
cultur
vitro
variou
overlap
lt
peptid
see
supplementari
tabl
overnight
stain
intracellular
ifnand
either
cell
surfac
marker
b
intracellular
cytokin
stain
follow
flow
cytometri
analysi
character
ltspecif
cell
epitop
use
variou
lt
overlap
peptid
splenocyt
harvest
mice
vaccin
note
ltspecif
cell
activ
c
intracellular
cytokin
stain
follow
flow
cytometri
analysi
character
ltspecif
cell
epitop
use
variou
lt
overlap
peptid
splenocyt
harvest
mice
vaccin
data
present
figur
one
experi
repres
two
perform
note
overlap
peptid
pool
activ
ltspecif
cell
identif
ltspecif
cell
epitop
use
splenocyt
stimul
variou
lt
overlap
peptid
intracellular
cytokin
stain
follow
flow
cytometri
analysi
character
ltspecif
cell
epitop
use
variou
lt
overlap
peptid
screen
group
compos
peptid
pool
splenocyt
harvest
mice
vaccin
use
method
similar
describ
fig
b
schemat
diagram
region
truncat
form
larg
antigen
ltspecif
cell
epitop
locat
sequenc
two
candid
ltspecif
cell
epitop
note
overlap
peptid
encod
ltspecif
epitop
activ
ltspecif
cell
